Last reviewed · How we verify
Hereditary factor VIII deficiency disease
Approved treatments
- Afstyla · CSL Behring GmbH
- Eptacog Alfa · Novo Nordisk
- Minirin · Hormozgan University of Medical Sciences
- Elocta · Swedish Orphan Biovitrum AB
- Refacto Af · Pfizer Ltd
- Hemlibra · Roche
Hemlibra works by binding to and activating factor IXa, a protein involved in blood clotting, to bypass the need for factor VIII. - Novoeight · Novo Nordisk
- Advate
- Nuwiq · Octapharma AB
- Ddavp · Ferring Pharms Inc
- Eloctate · University of Texas Southwestern Medical Center
- Argipressin · Kristina Svennerholm
- Esperoct · Novo Nordisk A/S
- Nuwiq · Emory University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hereditary factor VIII deficiency disease patent landscape — cliff calendar, originator estates, attackable patents
- Hereditary factor VIII deficiency disease treatment landscape brief
- Hereditary factor VIII deficiency disease treatment updates RSS
Frequently asked questions about Hereditary factor VIII deficiency disease
What drugs treat Hereditary factor VIII deficiency disease?
Tracked treatments include Afstyla, Eptacog Alfa, Minirin, Elocta, Refacto Af, Hemlibra, Novoeight, Advate.
What is the treatment for Hereditary factor VIII deficiency disease?
Standard treatment for Hereditary factor VIII deficiency disease includes Afstyla, Eptacog Alfa, Minirin, Elocta, Refacto Af. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hereditary factor VIII deficiency disease patent cliff · Hereditary factor VIII deficiency disease CI report
- Treatment: Afstyla · CSL Behring GmbH
- Treatment: Eptacog Alfa · Novo Nordisk
- Treatment: Minirin · Hormozgan University of Medical Sciences
- Treatment: Elocta · Swedish Orphan Biovitrum AB
- Treatment: Refacto Af · Pfizer Ltd
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing